Call Us Contact Us
+44 1494 818 000     Online Enquiry
Lines open
Monday to Thursday
08:30 to 18:00
Friday
08:30 to 17:30
Pharmaceutical | Medical Devices | Scientific | Consumer Healthcare | Dental | Animal Health
Healthcare Communications | Pharmaceutical Executive | Medical Executive | Tech PR | Scientific Executive
         
Latest Jobs
Exclusive vacancies may not be shown here, please contact Mark on +441494 818 049 or markd@zenopa.com for more information.
Have you registered?
Once you register you can see additional job details, save jobs, track your applications and manage e-lert preferences.

Register now
Mark Denton
Managing Director
markd@zenopa.com
+441494 818 049

Testimonials
Zenopa was extremely effective during my search for a new sales role. I was very pleased with the types of job role put forward and the consistent number of opportunities that my account manager conti...
Nina, 2013

Future Science Group journal to be covered by Chemical Abstracts

29 June 2011 00:00 in Marketing Services


Future Science Group's Therapeutic Delivery journal is to reach a wider audience after being selected for coverage by the Chemical Abstracts Service (CAS).

The American Chemical Society-run body is considered one of the most authoritative sources for chemical information, operating reputable databases such as CAS Registry.

Therapeutic Delivery is published monthly and focuses on the combination of technological, pharmacological, clinical and physiological aspects of modern therapeutics.

Future Science Group stated that it will be taking steps with its associate editors to ensure that the quality of the publication justifies its inclusion, such as making sure that the journal is up to date with the latest developments in the field.

Elisa Manzotti, editorial director of the Future Science series, said: "We would like to thank our editorial board for their hard work, intellectual input and guidance in targeting and evaluating topical, pioneering content."

This comes after another Future Science Group publication, Clinical Investigation, was also accepted for Chemical Abstracts coverage earlier this month.ADNFCR-8000103-ID-800603419-ADNFCR

Other news stories from 29/06/2011

Related news

Read more in the Zenopa News Archive

How this news is generated

Story collated for Zenopa by the Axonn News Agency



                    
© Copyright 2014 Zenopa Ltd